Open Accessibility Menu


Molecular testing utilizes polymerase chain reaction (PCR) technology to detect and confirm the presence of infectious diseases such as COVID-19. Bluewater implements PCR technology to determine whether a patient’s sample contains genetic material from a particular pathogen. PCR molecular identification is considered the gold standard in detecting pathogens like SARS-CoV-2. Detection of a pathogen can occur within days of exposure to the infection, even when individuals are asymptomatic.

Turnaround time for a PCR test is typically longer, averaging around two to three days, based on testing demands. It is encouraged to obtain a confirmation test via PCR molecular identification for individuals experiencing COVID-19 symptoms, or individuals with a high risk of exposure.

Bluewater Dx provides several molecular-based testing solutions for our healthcare partners:

  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Trichomonas vaginalis
  • SARS-CoV-2 (COVID-19)
  • Hepatitis C Viral Load Confirmation
  • QuantiFERON-TB Gold Plus